First

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 13.05.2022 / 12:00 The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ 1. Details of the person discharging managerial responsibilities / person closely associated a) Name ┌───────────────┬─────────────┐ │ Title: │ │ ├───────────────┼─────────────┤ │ First name: │ Harald │…

EQS-News: Österreichische Post AG / Key word(s): Quarter Results AUSTRIAN POST IN Q1 2022: Q1 2022 revenue and earnings below prior year as expected 13.05.2022 / 07:30 The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ AUSTRIAN POST IN Q1 2022: Q1 2022 revenue and earnings below prior year as expected Parcel division in consolidation phase after lockdown momentum of previous years – trend shift expected in H2 2022 earnings…

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.05.2022 / 18:35 The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ 1. Details of the person discharging managerial responsibilities / person closely associated a) Name ┌───────────────┬──────────┐ │ Title: │ Dr. │ ├───────────────┼──────────┤ │ First name: │ Wolfgang │…

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.05.2022 / 18:35 The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ 1. Details of the person discharging managerial responsibilities / person closely associated a) Name ┌───────────────┬──────────┐ │ Title: │ Dr. │ ├───────────────┼──────────┤ │ First name: │ Wolfgang │…

Rehovot, Israel (ots/PRNewswire) - - First EIB support for medtech investment in Israel - Financing to accelerate development of rapid testing system to improve infectious disease diagnosis and antibiotics stewardship - Automated phenotypic testing, revolutionizing infectious diseases diagnostics from sample to answer Research and development of fully automated testing of bacteria and infectious diseases by POCARED Diagnostics will be accelerated by EUR 22 million of European Investment Bank specialized venture debt…

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.05.2022 / 13:36 The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ 1. Details of the person discharging managerial responsibilities / person closely associated a) Name ┌───────────────┬────────┐ │ Title: │ DI Dr. │ ├───────────────┼────────┤ │ First name: │ Georg │…

München (ots) - Mischa Zverev übernimmt während der French Open die Rolle des Match-Analysten bei den Tennis-Übertragungen von Eurosport. Der 34-Jährige wird gemeinsam mit Moderator Matthias Stach in der Sendung "Matchball" zweimal am Tag auf die Partien im Stade Roland-Garros blicken, das Geschehen einordnen und bewerten sowie täglich als Co-Kommentator im Einsatz sein. Für Mischa Zverev ist es nicht der erste Einsatz im Eurosport-Team. Die ehemalige Nummer 25 der ATP-Weltrangliste begleitete unter anderem bereits den…

New therapeutic approach against rhinovirus infections Wien (OTS) - Less than three years after its foundation, the start-up G.ST Antivirals reaches a major milestone in the development of its lead asset and begins clinical phase I at the Vienna General Hospital. G.ST Antivirals is testing a nasal spray, which was developed specifically for use against colds and other upper respiratory tract infections. Based on years of research into metabolic changes in infected cells, the new nasal spray is designed to…

New therapeutic approach against rhinovirus infections Wien (OTS) - Less than three years after its foundation, the start-up G.ST Antivirals reaches a major milestone in the development of its lead asset and begins clinical phase I at the Vienna General Hospital. G.ST Antivirals is testing a nasal spray, which was developed specifically for use against colds and other upper respiratory tract infections. Based on years of research into metabolic changes in infected cells, the new nasal spray is designed to…

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 09.05.2022 / 19:25 The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ 1. Details of the person discharging managerial responsibilities / person closely associated a) Name ┌───────────────┬──────────┐ │ Title: │ Dr. │ ├───────────────┼──────────┤ │ First name: │ Wolfgang │…